Introduction & Background

The client is an American specialty pharmaceutical company engaged in developing, manufacturing, and marketing generic and proprietary pharmaceuticals, biopharmaceuticals, and active pharmaceutical ingredients. The client sought a contract manufacturer in India to produce finished formulations, with a key requirement being that the selected partner met US regulatory standards.

Objective: Identify and select a contract manufacturing partner in India with the necessary certifications and capabilities to meet US FDA standards.

‍

Tecnova’s Role

Phased Selection Approach

Conducted a detailed selection process in phases, starting with the identification of Indian companies with US FDA-approved plants and a portfolio of generic products that were expected to go off-patent soon.

‍

Key Criteria for Due Diligence

• Evaluated companies based on their experience with APIs and formulation synthesis, export history to regulated markets, and relevant accreditations.
• Other factors considered included:
• Site and facility performance
• Quality management systems and standards
• Regulatory experience with the FDA
• Bio-study capabilities
• Safety, hygiene, and environmental approvals
• Capacity for developing new generics and handling increased production for exports
• Financial stability and capacity to support long-term partnerships

‍

Implementation Phase

-Conducted site visits and in-person meetings between the client and shortlisted companies.

-Finalized the deal with a partner that met all regulatory, quality, and operational requirements.

‍

Outcome

Tecnova successfully facilitated the selection of a contract manufacturing partner with FDA-approved facilities, ensuring compliance with US standards and enabling the client to efficiently produce generic drugs in India.

‍

Conclusion

Tecnova’s strategic support helped the client navigate the complex landscape of contract manufacturing in India, ensuring compliance, quality, and scalability for their generic drug production.

‍